Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: In vitro and in vivo studies

Lung Cancer

Volumn 76, Issue 3, 2012, Pages 300-308

  Xue, Xia ^a,b   Sun, De Fu ^a   Sun, Cui Cui ^a   Liu, Hui Ping ^a   Yue, Bin ^a   Zhao, Cui Rong ^a   Lou, Hong Xiang ^a   Qu, Xian Jun ^a  

^a SHANDONG UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; Growth inhibition; Macrocyclic bisbibenzyl; Non small cell lung cancer; Riccardin D; Xenografts

Indexed keywords

BENZYL DERIVATIVE; CASPASE; CASPASE 3; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; GELATINASE A; GELATINASE B; GYRASE INHIBITOR; MACROCYCLIC COMPOUND; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLSERINE; RICCARDIN D; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG STRUCTURE; DUMORTIERA HIRSUTA; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; LIVERWORT; LUNG NON SMALL CELL CANCER; MOUSE; NICK END LABELING; NONHUMAN; PLANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA TOPOISOMERASES, TYPE II; FEMALE; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHENYL ETHERS; STILBENES; TOPOISOMERASE II INHIBITORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84862791952     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.12.013     Document Type: Article

References (43)

1. Niu C., Qu J.B., Lou H.X. Antifungal bis[bibenzyls] from the Chinese liverwort Marchantia polymorpha L. Chem Biodivers 2006, 3:34-40.
2. Scher J.M., Zapp J., Schmidt A., Becker H. Bazzanins L-R, chlorinated macrocyclic bisbibenzyls from the liverwort Lepidozia incurvata. Phytochemistry 2003, 64:791-796.
3. Xie C.F., Qu J.B., Wu X.Z., Liu N., Ji M., Lou H.X. Antifungal macrocyclic bis(bibenzyls) from the Chinese liverwort Ptagiochasm intermedlum L. Nat Prod Res 2010, 24:515-520.
4. Wu X.Z., Cheng A.X., Sun L.M., Sun S.J., Lou H.X. Plagiochin E, an antifungal bis(bibenzyl), exerts its antifungal activity through mitochondrial dysfunction-induced reactive oxygen species accumulation in Candida albicans. Biochim Biophys Acta 2009, 1790:770-777.
5. Shi Y.Q., Zhu C.J., Yuan H.Q., Li B.Q., Gao J., Qu X.J., et al. Marchantin C, a novel microtubule inhibitor from liverwort with anti-tumor activity both in vivo and in vitro. Cancer Lett 2009, 276:160-170.
6. Shen J., Li G., Liu Q., He Q., Gu J., Shi Y., et al. Marchantin C: a potential anti-invasion agent in glioma cells. Cancer Biol Ther 2010, 9:33-39.
7. Shi Y.Q., Qu X.J., Liao Y.X., Xie C.F., Cheng Y.N., Li S., et al. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells. Eur J Pharmacol 2008, 584:66-71.
8. Lu Z.Q., Fan P.H., Ji M., Lou H.X. Terpenoids and bisbibenzyls from Chinese liverworts Conocephalum conicum and Dumortiera hirsute. J Asian Nat Prod Res 2006, 8:187-192.
9. Xue X., Qu X.J., Gao Z.H., Sun C.C., Liu H.P., Zhao C.R., et al. Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II. Invest New Drugs 2010, 10.1007/s10637-010-9554-8.
10. Sun C.C., Zhang Y.S., Xue X., Cheng Y.N., Liu H.P., Zhao C.R., et al. Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma. Eur J Pharmacol 2011, 667:136-143.
11. Xiong R., Lu W., Li J., Wang P., Xu R., Chen T. Preparation and characterization of intravenously injectable nimodipine nanosuspension. Int J Pharm 2008, 350:338-343.
12. Hashimoto H., Sudo T., Maruta H., Nishimura R. The direct PAK1 inhibitor, TAT-PAK18, blocks preferentially the growth of human ovarian cancer cell lines in which PAK1 is abnormally activated by autophosphorylation at Thr 423. Drug Discov Ther 2010, 4:1-4.
13. Teng Y., Ren M.Q., Cheney R., Sharma S., Cowell J.K. Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases. Br J Cancer 2010, 103:1066-1075.
14. Dua P., Gude R.P. Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organization. Eur J Cancer 2008, 44:1587-1595.
15. Chen J.X., Zhao T., Huang D.X. Protective effects of edaravone against cobalt chloride-induced apoptosis in PC12 cells. Neurosci Bull 2009, 25:67-74.
16. Bacsó Z., Everson R.B., Eliason J.F. The DNA of annexin V-binding apoptotic cells is highly fragmented. Cancer Res 2000, 60:4623-4628.
17. Zhang X., Zhong J.L., Liu W., Gao Z., Xue X., Yue P., et al. N(3)-o-toluyl-fluorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU. Cancer Chemother Pharmacol 2010, 66:11-19.
18. 2 inhibits the growth of hepatocellular carcinoma via decrease of des-gamma-carboxy prothrombin. Chemotherapy 2009, 55:28-35.
19. Liu J., Li X., Cheng Y.N., Cui S.X., Chen M.H., Xu W.F. Inhibition of human gastric carcinoma cell growth by treatment of N(3)-o-toluyl-fluorouracil as a precursor of 5-fluorouracil. Eur J Pharmacol 2007, 574:1-7.
20. Okutucu B., Dincer A., Habib O., Zihnioqlu F. Comparison of five methods for determination of total plasma protein concentration. J Biochem Biophys Methods 2007, 70:709-711.
21. Park E.J., Shin J.H., Seo Y.S., Kim D.W., Hong S.Y., Park W.I., et al. Gonadotropin-releasing hormone-agonist induces apoptosis of human granulosa-luteal cells via caspase-8, -9 and -3, and poly-(ADP-ribose)-polymerase cleavage. Biosci Trends 2011, 5:120-128.
22. Yoon J.J., Lee Y.J., Kim J.S., Kang D.G., Lee H.S. Betulinic acid inhibits high glucose-induced vascular smooth muscle cells proliferation and migration. J Cell Biochem 2010, 111:1501-1511.
23. Yang S.Y., Jia X.Z., Feng L.Y., Li S.Y., An G.S., Ni J.H., et al. Inhibition of topoisomerase II by 8-chloro-adenosine triphosphate induces DNA double-stranded breaks in 8-chloro-adenosine-exposed human myelocytic leukemia K562 cells. Biochem Pharmacol 2009, 77:433-443.
24. Osheroff N., Shelton E.R., Brutlag D.L. DNA topoisomerase II from Drosophila melanogaster relaxation of supercoiled DNA. J Biol Chem 1983, 258:9536-9543.
25. Tan G., Gyllenhaal C., Soejarto D.D. Biodiversity as a source of anticancer drugs. Curr Drug Targets 2006, 7:265-277.
26. Li J.W., Vederas J.C. Drug discovery and natural products: end of an era or an endless frontier?. Science 2009, 325:161-165.
27. Harvey A.L. Natural products in drug discovery. Drug Discov Today 2008, 13:894-901.
28. Jordan M.A., Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004, 4:253-265.
29. Schiff P.B., Fant J., Horwitz S.B. Promotion of microtubule assembly in vitro by taxol. Nature 1979, 277:665-667.
30. Burden D.A., Kingma P.S., Froelich-Ammon S.J., Bjornsti M.A., Patchan M.W., Thompson R.B., et al. Topoisomerase II·etoposide interactions direct the formation of drug-induced enzyme-DNA cleavage complexes. J Biol Chem 1996, 271:29238-29244.
31. Lorence A., Nessler C.L. Camptothecin, over four decades of surprising findings. Phytochemistry 2004, 65:2735-2749.
32. Cheng A., Sun L., Wu X., Lou H. The inhibitory effect of a macrocyclic bisbibenzyl riccardin D on the biofilms of Candida albicans. Biol Pharm Bull 2009, 32:1417-1421.
33. Schwartner C., Michel C., Stettmaier K., Wagner H., Bors W. Marchantins and related polyphenols from liverwort: physicochemical studies of their radical-scavenging properties. Free Radic Biol Med 1996, 20:237-244.
34. Harinantenaina L., Quang D.N., Takeshi N., Hashimoto T., Kohchi C., Soma G., et al. Bis(bibenzyls) from liverworts inhibit lipopolysaccharide-induced inducible NOS in RAW 264.7 cells: a study of structure-activity relationships and molecular mechanism. J Nat Prod 2005, 68:1779-1781.
35. Shi Y.Q., Liao Y.X., Qu X.J., Yuan H.Q., Li S., Qu J.B., et al. Marchantin C, a macrocyclic bisbibenzyl, induces apoptosis of human glioma A172 cells. Cancer Lett 2008, 262:173-182.
36. Shieh D.E., Liu L.T., Lin C.C. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res 2000, 20:2861-2865.
37. Punathil T., Katiyar S.K. Inhibition of non-small cell lung cancer cell migration by grape seed proanthocyanidins is mediated through the inhibition of nitric oxide, guanylate cyclase and ERK1/2. Mol Carcinog 2009, 48:232-242.
38. Hung W.C., Tseng W.L., Shiea J., Chang H.C. Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. Cancer Lett 2010, 288:156-161.
39. Chetty C., Lakka S.S., Bhoopathi P., Rao J.S. MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells. Int J Cancer 2010, 127:1081-1095.
40. Bremnes R.M., Camps C., Sirera R. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer 2006, 51:143-158.
41. Chetty C., Bhoopathi P., Joseph P., Chittivelu S., Rao J.S., Lakka S. Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice. Mol Cancer Ther 2006, 5:2289-2299.
42. Munshi H.G., Wu Y.I., Mukhopadhyay S., Ottaviano A.J., Sassano A., Koblinski J.E., et al. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J Biol Chem 2004, 279:39042-39050.
43. Chetty C., Lakka S.S., Bhoopathi P., Kunigal S., Geiss R., Rao J.S. Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer. Cancer Res 2008, 68:4736-4745.